32 filings
8-K
SPRB
Spruce Biosciences Inc
30 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
SPRB
Spruce Biosciences Inc
13 Mar 24
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:12pm
8-K
SPRB
Spruce Biosciences Inc
8 Jan 24
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
8:00am
8-K
SPRB
Spruce Biosciences Inc
13 Nov 23
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
4:09pm
8-K
SPRB
Spruce Biosciences Inc
14 Aug 23
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
4:12pm
8-K
p02ecn 51vumlvemu
26 May 23
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
ryrtrs2yx2mw7i2
25 May 23
Departure of Directors or Certain Officers
8:16am
8-K
ovvvrhatp14h1gaiym
15 May 23
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
8:10am
8-K
1ffb1xo53 zmc1qxkl7
16 Mar 23
Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
4:07pm
8-K
i91aw 8pduk
9 Feb 23
Entry into a Material Definitive Agreement
4:33pm
8-K
zna ybznm3vze5oa
9 Jan 23
Entry into a Material Definitive Agreement
8:15am
8-K
2ure0
2 Dec 22
Entry into a Material Definitive Agreement
5:27pm
8-K
djp14dwrs
10 Nov 22
Spruce Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
4:14pm
8-K
qkq75p1v6zkm
10 Aug 22
Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:11pm
8-K
34bsct0
27 May 22
Submission of Matters to a Vote of Security Holders
12:00am
8-K
tm7fex dc6ym
11 May 22
Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:06pm
8-K
zd4 8xhgmrmcop81wd
8 Apr 22
Departure of Directors or Certain Officers
5:27pm
8-K
ykld0dsimbngij
14 Mar 22
Other Events
4:35pm
8-K
zachgh
14 Mar 22
Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
9wrh7 jxn0f1
5 Jan 22
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
5:04pm